Anna Brown

London, United Kingdom

Reporter at Endpoints News

Featured in: Favicon

endpts.com Favicon

newsbreak.com Favicon

bioprocessintl.com Favicon

invesbrain.com Favicon

pewresearch.org Favicon

theflorala.com

Articles

US drugs rely heavily on ingredients made overseas, new report shows

1 week ago | endpts.com | Anna Brown

Roughly 85% of the brand-name drugs prescribed in the US rely on ingredients sourced from other countries, according to a new report issued ahead of …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bayer opens $44M US expansion; Meribel CDMO launches in Europe

1 week ago | endpts.com | Anna Brown

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Biotech, CDMOs start to disclose tariff exposure with US trade inquiry underway

1 week ago | endpts.com | Anna Brown

Many parts of the pharma supply chain could be at risk as the Commerce Department investigates the sector for potential tariffs. But …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pharma tariffs could leave little room to hide with sweeping probe underway

1 week ago | endpts.com | Anna Brown

A US trade probe into pharmaceuticals is underway. And it’s hitting many of the key aspects of the supply chain. The investigation, announced Monday, will … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pharma tariffs to arrive ‘in the next month or two,’ commerce secretary says

1 week ago | endpts.com | Anna Brown

Commerce Secretary Howard Lutnick has indicated more specific timelines as to when pharma tariffs could surface, noting they are “coming in the next month or …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
CDMOs anticipate inspection bottlenecks after mass FDA firings

2 weeks ago | endpts.com | Anna Brown

CDMOs fear that FDA site inspections might slow down due to the mass staffing cuts at the federal health agencies. Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Here’s what a potential rollout could look like

2 weeks ago | endpts.com | Anna Brown

This week, much of the world got a reprieve from President Donald Trump’s tariffs. Drugmakers might not be so fortunate. In recent days, Trump has … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pharma is next in line as Trump says tariffs are coming ‘very shortly’

2 weeks ago | endpts.com | Anna Brown

President Donald Trump warned on Tuesday evening that “major” pharmaceutical tariffs will be coming “very shortly,” after previously exempting drugs from his earlier levy announcements … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Drug tool and packaging makers to feel brunt of Trump tariffs, analysts say

2 weeks ago | endpts.com | Anna Brown

Pharma tool and packaging production companies are readying themselves for direct impact from President Donald Trump’s tariffs, which could then have a knock-on effect on …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Cell and gene therapy CDMO AmplifyBio shuts down over ‘scarcity’ of funding

2 weeks ago | endpts.com | Anna Brown

Another CDMO has been hit by the slowdown of cell and gene therapy R&D. AmplifyBio closed its doors after struggling for months to find investor …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.